LYNN NEARY, host: Now, the story of some students who arrived as foreigners in Russia. When New York Times reporter Clifford Levy and his wife Julie Dressner moved to Russia five years ago they chose to use the time to fully immerse their children in the country, opting for a Russian education over the local international school.
LYNN NEARY, host: Three scientists have been awarded the Nobel Prize in physiology or medicine for their work on understanding the immune system. However, it turns out one of the scientists died several days ago, which could mean that he was not eligible for the prize. Joining us now is NPR science correspondent Jon Hamilton.
Thanks for joining us, Jon.
JON HAMILTON: Good to be here.
NEARY: Let's start with this scientist who died. Who was he, and why might his death make him ineligible for the Nobel Prize?
American Amanda Knox has a chance at freedom after spending four years behind bars in Italy. An Italian appeals court will decide Monday whether she killed her British roommate. Knox, who says she's innocent, was convicted in 2009 along with Raffaele Sollecito in the death of fellow student Meredith Kercher. David Greene talks about the trial with Barbie Nadeau, a reporter for Newsweek, who has written a book about the trial.
Residents of the Libyan capital Tripoli are growing increasingly angry at abuses said to be carried out by armed anti-Gadhafi groups. Some allege that once rebel fighting brigades have become criminal gangs, looting and intimidating at will.
NPR's board of directors announced Sunday that it had dipped into the world of public television for its new president and CEO: Gary E. Knell, chief executive of the company behind the beloved children's show Sesame Street.
Knell, 57, said he hopes to "calm the waters" at NPR after a rocky year in which the institution lost several top executives and faced renewed challenges to its funding.
Drug shortages mean a growing number of Americans aren't getting the medications they need. That's causing drug companies and doctors to ration available medications in some cases.
"We're now at 213 shortages for this year," says Erin Fox of the University of Utah, who tracks national drug shortages. "That surpasses last year's total of 211. And it doesn't seem like there's an end in sight."